We are live on ! Find out more
WCBA

Weaver C. Barksdale & Associates Portfolio holdings

AUM $105M
1-Year Est. Return 13.81%
This Fund
S&P 500
This Quarter Est. Return
+0.93%
1 Year Est. Return
+13.81%
3 Year Est. Return
+40.08%
5 Year Est. Return
10 Year Est. Return
AUM
$85.7M
AUM Growth
+$817K
Cap. Flow
+$429K
Cap. Flow %
0.5%
Top 10 Hldgs %
19.06%
Holding
557
New
35
Increased
169
Reduced
196
Closed
43

Sector Composition

Rank Sector Weight
1 Financials 17.97%
2 Technology 13.46%
3 Industrials 12.4%
4 Healthcare 12.18%
5 Consumer Discretionary 11.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VAL
526
DELISTED
Valspar
VAL
-197
Closed -$22K
JNS
527
DELISTED
Janus Capital Group Inc
JNS
-81,537
Closed -$1.08M
BEAV
528
DELISTED
B/E Aerospace Inc
BEAV
-238
Closed -$15K
JOY
529
DELISTED
Joy Global Inc
JOY
-439
Closed -$12K
CEB
530
DELISTED
CEB Inc.
CEB
-62
Closed -$5K
CSC
531
DELISTED
Computer Sciences
CSC
-568
Closed -$39K
BBEP
532
DELISTED
BREITBURN ENERGY PARTNERS LP COM UNITS RPTNG LTD PRTNRSHIP
BBEP
-646
Closed
CEO
533
DELISTED
CNOOC Limited
CEO
-8
Closed -$1K
WWAV
534
DELISTED
The WhiteWave Foods Company
WWAV
-401
Closed -$23K
RINO
535
DELISTED
RINO International Corporation Common Stock
RINO
$0 ﹤0.01%
40

Similar funds

Weaver C. Barksdale & Associates's Q2 2017 Portfolio in Review

As of Q2 2017, Weaver C. Barksdale & Associates held 557 positions worth $85.7M, up 0.96% from $84.9M the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Weaver C. Barksdale & Associates's Q2 2017 filing shows 35 new, 169 increased, 196 reduced and 43 closed positions. Its largest new stake was Texas Instruments: 18,827 shares worth $1.45M. The largest sale was Novartis, an estimated $1.29M.

By sector, the portfolio is most concentrated in Financials at 18% of assets, down from 19% a quarter earlier, followed by Technology and Industrials.

  • Weaver C. Barksdale & Associates's largest Q2 2017 buy was Texas Instruments: 18,827 shares worth $1.45M.
  • Weaver C. Barksdale & Associates added most to Marathon Petroleum in Q2 2017, an estimated $819K increase.
  • Weaver C. Barksdale & Associates's biggest Q2 2017 reduction was Alliance Resource Partners, cutting an estimated $337K.
  • Weaver C. Barksdale & Associates fully exited Novartis in Q2 2017, selling an estimated $1.29M.
  • Weaver C. Barksdale & Associates's ten largest holdings make up 19% of its $85.7M portfolio in Q2 2017.
  • Weaver C. Barksdale & Associates opened 35 new positions and closed 43 in Q2 2017.
  • Weaver C. Barksdale & Associates's portfolio value rose 0.96% quarter-over-quarter to $85.7M.

Based on Weaver C. Barksdale & Associates's 13F filing for Q2 2017, filed 13 Jul 2017.